Ulrik Tarp
Aarhus University Hospital(DK)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Monoclonal and Polyclonal Antibodies Research, Selenium in Biological Systems, Autoimmune and Inflammatory Disorders Research
Most-Cited Works
- → Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry(2009)537 cited
- → MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)(2008)364 cited
- → Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti–tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry(2010)244 cited
- → Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries(2011)223 cited
- → Clinical Response, Drug Survival, and Predictors Thereof Among 548 Patients With Psoriatic Arthritis Who Switched Tumor Necrosis Factor α Inhibitor Therapy: Results from the Danish Nationwide DANBIO Registry(2013)202 cited